1. Sharma TD, Singh TT, Laishram RS, Sharma LDC, Sunita AK, Imchen LT. Nasopharyngeal Carcinoma- A Clinico-pathological Study in a Regional Cancer Centre of North-eastern India. Asian Pacific J Cancer. 2011; 12: 1583-7.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
3. Ferley J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, method and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5): 359-86.
4. Kumar S , Zinyu R , Singh IKK , Medhi SB, Baruah T, Das B, et al. Studies on Nasopharyngeal cancer with reference to the North-Eastern region of India. Ann Natl Acad Med Sci. 1996; 32:199.
5. Wei KR, Xu Y, Liu J, Zhang WJ, Liang ZH. Histopathological Classification of Nasopharyngeal Carcinoma. Asian Pacific J Cancer. 2011; 12:
1141-47.
6. Krishna SM , James S, Sreelekha TT, Kattoor J, Balaram P. Primary Nasopharyngeal Cancer of Indian Origin and the Viral Link - A Preliminary Study. Asian J of Cancer. 2006; 5: 241-52.
7. Liu MT, Hsieh CY, Chang TH, Lin JP, Huang CC, Wang AY. Prognostic factor affecting the outcome of nasopharyngeal carcinoma. Jpn J clin oncol. 2003; 33(10): 501-8.
8. Jitani AK , Raphael V , Mishra J , Shunyu NB, Khonglah Y, Medhi J . Analysis of Human Papilloma Virus 16/18 DNA and its correlation with p16 expression in oral cavity squamous cell carcinoma in North Eastern India : A chromogenic in situ hybridization based study. J Clin Diagn Res. 2015; 9(8): EC04-7.
9. Chang ET, Adami HO. The Enigmatic Epidemiology of Nasopharyngeal Carcinoma. Cancer Epidemiol Biomarkers. 2006; 15: 1765-77.
10. Macmohan B. Epidemiology and Hodgkin disease. Cancer Res. 1966; 26: 1189-201.
11. Brooks L, Yao QY, Rickinson AB, Young LS. Epstein Barr Virus latent gene transcription in nasopharyngeal carcinoma cells: co-expression of EBNA1, LMP1 and LMP2 transcripts. J Virol. 1992; 66(5): 2689-97.
12. Pathmanathan R, Prasad U, Chandrika G, Sadler R,
Flynn K,
Raab-Traub N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Am J Pathol. 1995; 146(6): 1355-67.
13. Cheng YJ,
Hildesheim A,
Hsu MM,
Chen IH, A. Brinton L, H. Levine O, et al. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan.
Cancer Causes Control. 1999; 10(3): 201-7.
14. Chen L,
Gallicchio L, Boyd-
Lindsley K, Tao XG, Robinson KA, Lam TK, et al. Alcohol consumption and the risk of Nasopharyngeal carcinoma: A systemic review. Nutr Cancer. 2008; 61: 1-15.
15. Kataki AC,
Simons MJ,
Das AK,
Sharma K,
Mehra NK. Nasopharyngeal carcinoma in the North-eastern states of India.
Chin J Cancer. 2011; 30(2): 106-13.
16. Tsai ST, Jin YT, Mann RB, Ambinder RF. Epstein-barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Cancer. 1998; 82(8): 1449-53.
17. Wu TC, Mann RB, Epstein IJ, MacMahon E, Lee WA,
Charache P, et al. Abundant Expression of EBER1 Small Nuclear RNA in Nasopharyngeal Carcinoma: A Morphologically Distinctive Target for Detection of Epstein-Barr Virus in Formalin-fixed Paraffin-embedded Carcinoma Specimens. Am J Pathol. 1991; 138(6): 1461-69.
18. Hanel P, Hummel M, Anagnostopoulos I, Stein H. Analysis of single EBER-positive and negative tumour cells in EBV-harbouring B-cell non-Hodgkin lymphomas.
J Pathol. 2001; 195(3): 355-60.
19. Broussset P, Butet V, Chittal S, Selves J,
Delsol G. Comparison of in-situ hybridization using different non isotopic probes for detection of EBV in nasopharyngeal carcinoma and IHC correlation with anti-latent membrane protein antibody. Lab Invest. 1992; 67(4): 457-64.
20. Murono S, Yoshizaki T, Tanaka S, Takeshita H, Park C, Furukawa M. Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction. Laryngoscope. 1997; 107(4): 523-26.
21. Mäkitie AA, MacMillan C, Ho J, Shi W,
Lee A,
O’Sullivan B, et al. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. Clin Cancer Res. 2003; 9: 2177-84.